Prenetics Secures $70M From Tencent Sale, Lifts Liquidity to $171.1M
Prenetics completed the sale of its 35% Insighta stake to Tencent for $70 million, receiving $69 million upfront and boosting adjusted liquidity to $171.1 million while maintaining zero debt. This final strategic transformation milestone underpins accelerated global expansion of its IM8 consumer health brand.
1. Completion of $70M Insighta Stake Sale
Prenetics finalized the sale of its 35% equity interest in Insighta to Tencent for total cash consideration of $70 million, receiving $69 million on February 13, 2026 with $1 million held in escrow.
2. Strengthened Liquidity and Balance Sheet
The transaction elevated Prenetics’ total adjusted liquidity to $171.1 million, comprising $99.3 million in cash, $29.3 million in financial assets, $6.3 million in escrow and $35.2 million in alternative assets, while the company continued to operate with zero debt.
3. Strategic Focus on IM8 Expansion
With IM8 having surpassed $100 million in annualized recurring revenue within 11 months and distribution in over 30 countries, Prenetics intends to direct the newly fortified balance sheet toward global rollout, clinical trials and product innovation for its flagship consumer health brand.
4. Upcoming Earnings and Outlook
Prenetics will report its fourth-quarter and full-year 2025 financial results in a pre-market release on February 18, 2026, offering investors an updated view of its strengthened financial position and growth strategy.